Pages

Friday, March 24, 2017

US FDA News: HeartStart MRx Monitor/Defibrillator by Phillips Healthcare: Class I Recall - Electrical Issues

A delay in delivering therapy could result in serious patient injury such as permanent organ damage, brain injury, or death.
Read more: HeartStart MRx Monitor/Defibrillator by Phillips Healthcare: Class I Recall - Electrical Issues